Kerri Fitzgerald

Kerri Fitzgerald

Kerri Fitzgerald

Kerri Fitzgerald is a medical writer and editor with over 10 years of experience writing mostly in the hematology/oncology space. She can be reached at kfitzgerald@mashupmd.com.

Articles by Kerri Fitzgerald

Kerri FitzgeraldConferences | June 14, 2022
The results were presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
Read More
Kerri FitzgeraldConferences | June 14, 2022
Just 38% of patients with breast cancer receive at least 1 palliative care consult following metastatic disease diagnosis.
Kerri FitzgeraldConferences | June 14, 2022
All stakeholders have a role to play in increasing representation in this patient population.
Kerri FitzgeraldConferences | June 14, 2022
A study identified self-reported gaps from healthcare providers associated with providing treatment-related support.
Kerri FitzgeraldMPN | April 7, 2021
A study published in Kidney International Reports found that kidney involvement is heterogenous in patients with chronic ...
Kerri FitzgeraldMyelofibrosis | April 7, 2021
A study published in Transplant and Cellular Therapy assessed outcomes in patients with myelofibrosis (MF) who choose to ...
Kerri FitzgeraldMPN | April 7, 2021
A study published in Hematology/Oncology and Stem Cell Therapy observed no significant difference in the rate of thrombotic ...
Kerri FitzgeraldMPN | April 7, 2021
Decitabine with or without ruxolitinib is beneficial for patients with advanced myeloproliferative neoplasms (MPN) when ...
Kerri FitzgeraldMyelofibrosis | March 9, 2021
A study presented as part of the ASH 2020 Annual Meeting found that use of fedratinib for 24 or more weeks was well-tolerated ...
Kerri FitzgeraldMyelofibrosis | March 9, 2021
Interferon-alpha (rIFN?) is the only disease-modifying treatment option for polycythemia vera (PV). A study published in ...